Related references
Note: Only part of the references are listed.Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
Katherine H. Schreiber et al.
AGING CELL (2015)
Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer
Ritu Malla et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways
Ritu Malla et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors
Theresa D. Carr et al.
CARCINOGENESIS (2015)
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
David J. Kwiatkowski et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2
Christl Gaubitz et al.
MOLECULAR CELL (2015)
Nutrient-sensing mechanisms and pathways
Alejo Efeyan et al.
NATURE (2015)
mTORC1-mediated translational elongation limits intestinal tumour initiation and growth
William J. Faller et al.
NATURE (2015)
mLST8 Promotes mTOR-Mediated Tumor Progression
Kyoko Kakumoto et al.
PLoS One (2015)
Mutations in Mammalian Target of Rapamycin Regulator DEPDC5 Cause Focal Epilepsy with Brain Malformations
Ingrid E. Scheffer et al.
ANNALS OF NEUROLOGY (2014)
DEPDC5 Mutations in Genetic Focal Epilepsies of Childhood
Dennis Lal et al.
ANNALS OF NEUROLOGY (2014)
Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders
Jessica A. Burket et al.
BRAIN RESEARCH BULLETIN (2014)
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Atsushi Umemura et al.
CELL METABOLISM (2014)
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
Sebastiano Sciarretta et al.
CIRCULATION RESEARCH (2014)
Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma
Carlos Rodrigo Gil del Alcazar et al.
CLINICAL CANCER RESEARCH (2014)
The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the elF4B-Dependent Control of c-Myc Translation
Alfredo Csibi et al.
CURRENT BIOLOGY (2014)
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function
Kristin P. Bibee et al.
FASEB JOURNAL (2014)
Targeting mTOR dependency in pancreatic cancer
Douglas C. Morran et al.
GUT (2014)
Phosphorylation of PRAS40-Thr246 Involved in Renal Lipid Accumulation of Diabetes
Jun Hao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Coordinated regulation of protein synthesis and degradation by mTORC1
Yinan Zhang et al.
NATURE (2014)
Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus
Pengda Liu et al.
NATURE (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Guomei Tang et al.
NEURON (2014)
Pancreatic tumours escape from translational control through 4E-BP1 loss
Y. Martineau et al.
ONCOGENE (2014)
FMRP S499 Is Phosphorylated Independent of mTORC1-S6K1 Activity
Christopher M. Bartley et al.
PLOS ONE (2014)
Reassessment of the Role of TSC, mTORC1 and MicroRNAs in Amino Acids-Meditated Translational Control of TOP mRNAs
Ilona Patursky-Polischuk et al.
PLOS ONE (2014)
Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown
Ankur Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Marion Cornu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Regulation of mTORC1 by amino acids
Liron Bar-Peled et al.
TRENDS IN CELL BIOLOGY (2014)
Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner
Rachel Miloslavski et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
Brian C. Grabiner et al.
CANCER DISCOVERY (2014)
Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes
Christos G. Gkogkas et al.
CELL REPORTS (2014)
Late-life rapamycin treatment reverses age-related heart dysfunction
James M. Flynn et al.
AGING CELL (2013)
Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Darcy A. Krueger et al.
ANNALS OF NEUROLOGY (2013)
Conserved sequence motifs and the structure of the mTOR kinase domain
Evelyn Sauer et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Autism spectrum disorder in the genetics clinic: a review
M. T. Carter et al.
CLINICAL GENETICS (2013)
mTOR in aging, metabolism, and cancer
Marion Cornu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Adverse events associated with mTOR inhibitors
Nicolas Pallet et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration
Monica Dalal et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Coexistent mutations of KRAS and PIK3CA affect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer
Areumnuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Dudley W. Lamming et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Metabolic Stress Controls mTORC1 Lysosomal Localization and Dimerization by Regulating the TTT-RUVBL1/2 Complex
Sang Gyun Kim et al.
MOLECULAR CELL (2013)
Autism-related deficits via dysregulated eIF4E-dependent translational control
Christos G. Gkogkas et al.
NATURE (2013)
Exaggerated translation causes synaptic and behavioural aberrations associated with autism
Emanuela Santini et al.
NATURE (2013)
mTOR kinase structure, mechanism and regulation
Haijuan Yang et al.
NATURE (2013)
Sinl phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis
Pengda Liu et al.
NATURE CELL BIOLOGY (2013)
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
Christian C. Dibble et al.
NATURE CELL BIOLOGY (2013)
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Leanne M. Dibbens et al.
NATURE GENETICS (2013)
Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
Darcy A. Krueger et al.
NEUROLOGY (2013)
MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
Chitose Oneyama et al.
PLOS ONE (2013)
Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
Issam Ben-Sahra et al.
SCIENCE (2013)
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Aaron M. Robitaille et al.
SCIENCE (2013)
A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1
Liron Bar-Peled et al.
SCIENCE (2013)
Nutrient signaling to mTOR and cell growth
Jenna L. Jewell et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome Implications for normal aging and age-dependent neurodegenerative disorders
John J. Graziotto et al.
AUTOPHAGY (2012)
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Tommy Alain et al.
CANCER RESEARCH (2012)
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1
Liron Bar-Peled et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Shile Huang et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2
Minsheng Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Christian C. Dibble et al.
MOLECULAR CELL (2012)
A unifying model for mTORC1-mediated regulation of mRNA translation
Carson C. Thoreen et al.
NATURE (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
Aditi Bhattacharya et al.
NEURON (2012)
Distinct perturbation of the translatome by the antidiabetic drug metformin
Ola Larsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Dudley W. Lamming et al.
SCIENCE (2012)
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
C. De Palma et al.
CELL DEATH & DISEASE (2012)
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
Atsushi Sato et al.
NATURE COMMUNICATIONS (2012)
An Evolving Role for DEPTOR in Tumor Development and Progression
Zhiwei Wang et al.
NEOPLASIA (2012)
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer
E. E. Vincent et al.
BRITISH JOURNAL OF CANCER (2011)
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Timothy R. Peterson et al.
CELL (2011)
High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy
Falguni Das et al.
CELLULAR SIGNALLING (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Translational coregulation of 5′TOP mRNAs by TIA-1 and TIAR
Christian Kroun Damgaard et al.
GENES & DEVELOPMENT (2011)
Activating mutations of TOR (target of rapamycin)
Molly Hardt et al.
GENES TO CELLS (2011)
Target of Rapamycin (TOR) in Nutrient Signaling and Growth Control
Robbie Loewith et al.
GENETICS (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V. Serra et al.
ONCOGENE (2011)
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
Nina Ilic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
Yonghao Yu et al.
SCIENCE (2011)
The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
Peggy P. Hsu et al.
SCIENCE (2011)
mTOR signaling in polycystic kidney disease
Oxana Ibraghimov-Beskrovnaya et al.
TRENDS IN MOLECULAR MEDICINE (2011)
mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
Vanessa S. Rodrik-Outmezguine et al.
CANCER DISCOVERY (2011)
Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis
Zhi Hong Lu et al.
CANCER RESEARCH (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
Andrew C. Hsieh et al.
CLINICAL CANCER RESEARCH (2010)
Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells
Boris Shor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
mTORC1 Directly Phosphorylates and Regulates Human MAF1
Annemieke A. Michels et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
Calvin K. Yip et al.
MOLECULAR CELL (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
Association of Gly972Arg polymorphism of IRS1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study
Ana I. Burguete-Garcia et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
T. Sato et al.
ONCOGENE (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1
Theodoros Kantidakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
David A. Guertin et al.
CANCER CELL (2009)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
Protein kinase C intervention-the state of play
Jon Roffey et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Emerging common themes in regulation of PIKKs and PI3Ks
Harri Lempiaeinen et al.
EMBO JOURNAL (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chong Chen et al.
SCIENCE SIGNALING (2009)
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin
Cristiane H. Squarize et al.
CANCER RESEARCH (2008)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro
A. Stahl et al.
FEBS LETTERS (2008)
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events
Caterina Nardella et al.
GENES & DEVELOPMENT (2008)
S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade
Usha Narayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Beth Apsel et al.
NATURE CHEMICAL BIOLOGY (2008)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome
M. Sanchez-Cespedes
ONCOGENE (2007)
Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the old order Amish
Evadnie Rampersaud et al.
DIABETES (2007)
Cognitive deficits in Tsc1+/-mice in the absence of cerebral lesions and seizures
Susanna M. I. Goorden et al.
ANNALS OF NEUROLOGY (2007)
Identification of Protor as a novel Rictor-binding component of mTOR complex-2
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions
M. Nanjundan et al.
ONCOGENE (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14
Georg Bohn et al.
NATURE MEDICINE (2007)
S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N. Valerio Dorrello et al.
SCIENCE (2006)
MTOR, translation initiation and cancer
Y. Mamane et al.
ONCOGENE (2006)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
MK Holz et al.
CELL (2005)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology
RJ Griffin et al.
JOURNAL OF NEUROCHEMISTRY (2005)
PRR5 encodes a conserved proline-rich protein predominant in kidney:: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas
CN Johnstone et al.
GENOMICS (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases
B Raught et al.
EMBO JOURNAL (2004)
Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells
FD Sigoillot et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
mTOR-dependent activation of the transcription factor TIMA links rRNA synthesis to nutrient availability
C Mayer et al.
GENES & DEVELOPMENT (2004)
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies
OJ Shah et al.
CURRENT BIOLOGY (2004)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
SKAR is a specific target of S6 kinase 1 in cell growth control
CJ Richardson et al.
CURRENT BIOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease
WL An et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes:: a meta-analysis of 27 studies
A Jellema et al.
DIABETOLOGIA (2003)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
XM Wang et al.
EMBO JOURNAL (2001)
Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex
KF Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
